Best Immunotherapy with (Pembolizumab) oncologists: TOP 57 doctors

Deputy Head of the Department of Oncology. One of the leading Israeli specialists in the digestive tract tumors, sarcoma and melanoma

Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.

Head of Neurooncology Clinic of Ichilov

Prof. Peled is a leading specialist in lung cancer immunotherapy, with expertise in Internal Medicine, Pulmonology and Medical Oncology. He has received the ASCO Merit Award, and is the head of the Thoracic Cancer Unit at Davidoff Cancer Center and Head of the Research and Detection Unit for Thoracic malignancies at Sheba Medical Center. He is a member of the Thoracic Oncology Assembly of the European Respiratory Society and Chair of the Early Detection and Prevention Committee of the International Association for the Study of Lung Cancer.

• Specialized in immunotherapy with for pediatric cancers.
• Trained in Pediatric Hematology and Oncology in the USA.
• Member of international pediatric oncology societies.
• Doctorate from the University of Barcelona, Spain.
• Directed units in top Spanish hospitals.

• Specializes in immunotherapy with for hematologic cancers.
• Trained in Japan and Turkey, enhancing his expertise in advanced therapies.
• Member of several international hematology and oncology associations.
• Published extensively on hematologic malignancies and treatment methods.
• Holds a PhD in Hematology from Japan Mie Medical Faculty.

Prof. Baytan is a doctor who graduated from Ankara University Medical Faculty in 1992 and became a Specialist in Medicine at Uludağ University Faculty of Medicine, Department of Child Diseases. He is experienced in the diagnosis and treatment of childhood cancers, leukemia, anemia, and other diseases. He has 15 articles published in international refereed journals, 9 full texts presented and published in international scientific meetings, 3 books/book chapters written, and 8 articles published in local refereed journals.

Dr. Girish V. Badarkhe is an experienced hematology-oncologist at HCG Manavata Cancer Centre, Nashik, with MBBS, MD, and DM degrees. He has 13+ years of expertise in leukemia, multiple myeloma, and transplant, and has received awards for his professional and hard work.

Prof. Songul Serefhanoglu is a Hematologist at ISU Medical Park since 2019, and has been the Director and President of Adult Hematology Department of Sisli Memorial Hospital, Istanbul since 2019. He completed his Medical Education from Firat University, Elazig/Turkey (1994-2000), Internal Medicine from Inonu University, Malatya/Turkey (2001-2005), and Hematology from Hacettepe University, Ankara/Turkey (2006-2009). He has been involved in peripheral hematopoietic stem cell transplantation, with an average of 100-120/year.

Dr. Raj is a highly experienced Surgical Oncologist with 19 years of experience and over 50,000 cancer surgeries performed. He is involved in numerous clinical trials and has many international and national publications to his credit. He specializes in Breast and Thoracic Surgical Oncology and serves as a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at the Maharashtra University of Health Sciences. His belief is in "adding life to years" and improving the quality of life, not just adding years to life.

• Specializes in immunotherapy with for hematological malignancies.
• Trained in Immunology in Germany, extensive international lectures.
• Member of the German Society of Hematology and Medical Oncology.
• Provides remote consultations for immunotherapy with .
• Chief Physician at the Oncology and Hematology Center, Bremen.

Prof. Dr. Osman İLHAN graduated from Ankara University Faculty of Medicine in 1978. After completing his internal medicine residency at the same faculty in 1982, he served as a senior resident at the GATA Hematology Clinic during his military service. After completing his mandatory service at SSK Ulus Hospital, he returned to Ankara University Faculty of Medicine for a subspecialty. In 1990, he became an associate professor of hematology. He worked in Genoa, Italy to increase his knowledge and experience in leukemia. He was part of the team that performed the first stem cell transplant in Turkey. In 1996, he went to the MD Anderson Cancer Center in the USA to work on " Cell Mobilization, Cryopreservation, and Transplantation." In 1996, he became a professor of hematology. In 1999, he was elected as the regional president of ESFH (European Society for Hemapheresis). Dr. İlhan, who was the founder and president of the Hemapheresis Society in 2000, joined the World Apheresis Association (WAA) in 2001. He became the President of the Turkish Hematology Association in October 2001. Dr. İlhan, who is an active member of the European Hematology Association (EHA), was a member of the accreditation committee (ECAH) for education. He played a role in the accreditation of Turkish hematologists in CME credits by participating in the accreditation of congresses and courses held in Turkey as a Provider Status. He served as the founding president of the Cellular Therapy and Regenerative Medicine Association established in 2008. He became the founding president of the Geriatric Hematology Association in 2011. He is the Honorary President of the World Apheresis Congress (WAA) held in 2012. Dr. İlhan, who previously served on drug licensing and ethics committees at the Ministry of Health, has also served as the Chairman of the Photopheresis-Apheresis Commission and the Scientific Committee for Bone Marrow Transplantation, as well as the Chairman of the National Organ Tissue Cell Coordination Board, the Scientific Board of Cord Blood, and the Cell Research Board. He is the founding president of the FOUNDATION and has played an important role in the establishment of TURKOK (Turkish Cell Donor Bank). Dr. İlhan has over 300 publications in journals registered in PubMed and more than 5000 citations. He holds the Platinum CME certificate from the European Hematology Association. He owns four brands/patents named “Kökten Çözüm (Deep Solution), Telehematoloji (Telehematology), Hemaferez (Hemapheresis), Kanser Kök Hücresi (Cancer Cell)”. He is currently the President of the Ankara Medical Association. Prof. Dr. Osman İlhan, who served at Ankara University Faculty of Medicine for 50 years, began working at Özel Koru Ankara Hospital as of January 1, 2023.

His medical interests include:

Hematopoietic Cell Transplantation (, )

Acute Leukemia

Chronic Leukemia Treatments

Hodgkin Lymphoma

Non-Hodgkin Lymphoma Treatments

Multiple Myeloma Treatments, MDS

Aplastic Anemia

ITP

TTP Treatments

Hypercoagulability

Hereditary Thrombophilia Treatments

Therapeutic Apheresis

Photopheresis

Geriatric Hematology Diseases.

Experienced medical oncology specialist with 11 years of experience, having worked in various medical facilities including Pamukkale University Faculty of Medicine, Hakkari State Hospital, Dr. Lütfi Kırdar Kartal Training and Research Hospital and Edirne Sultan Murat I State Hospital. Member of the Turkish Medical Oncology Association, European Society of Medical Oncology, American Society of Clinical Oncology, Immuno-Oncology Association and Turkish Medical Association.

Dr. X has a Bachelor of Medicine from Ankara (1976), Specialization in Internal Medicine from Ankara (1981), and a Minor Specialization in Medical Oncology from Istanbul (1987). He has held various positions in Oncology and Internal Medicine since 1986, and is a Founding Member and active member of various oncology associations and scientific organizations such as the Turkish Oncology Association, Medical Oncology Association, Chemotherapy Association, European Society for Medical Oncology, American Society of Clinical Oncology, and European Association for Clinical Cancer Research.